Description
“CIIP - Brazil with Genotyping” The aim of this project is to develop a novel method to isolate and detect pathogens causing Blood Stream Infections (BSI). Initially, a sensitive kit will be developed to isolate DNA from all the microorgani…
Amendment chain · 1 entry
Each notch is one published row for this agreement: #0 is the original (placed at its start date) and each later notch is an amendment (placed at its amendment date). The height is the agreement's total value as of that row — the source column is cumulative, not a change amount — so the line reads as the commitment over time and the right-most notch is the current commitment shown in the header.
- #02018-07-01$259,000
| Row | Date | Total value as of row | Change vs previous | Description on this row |
|---|---|---|---|---|
| #0 original | 2018-07-01(start date) | $259,000 | — | “CIIP - Brazil with Genotyping” The aim of this project is to develop a novel method to isolate and detect pat… |
Related records · 7
Records are related by an explicit link in the data, stated for each group below — never by text similarity. Values are each agreement's current commitment (latest amendment).
Other current agreements for the same recipient (business number 870378197)
| Ref | Department · program | Current value | FY |
|---|---|---|---|
| 172-2024-2025-Q2-1020870 | National Research Council Canada | Conseil national de recherches Canada · Industrial Research Assistance Program – Contributions to Firms | $349,868 | FY2025 |
| 172-2023-2024-Q2-1008267 | National Research Council Canada | Conseil national de recherches Canada · CanExport SME | $13,000 | FY2024 |
Other recipients funded under "Canadian International Innovation Program" by National Research Council Canada | Conseil national de recherches Canada (most recent first)
| Ref | Recipient | Fiscal year | Current value | FY |
|---|---|---|---|---|
| 172-2026-2027-Q1-1043374 | Ayrton Energy Inc. | FY2027 | $600,000 | FY2027 |
| 172-2026-2027-Q1-1044079 | Aspin Kemp & Associates Inc. | FY2027 | $599,808 | FY2027 |
| 172-2026-2027-Q1-1042940 | DCL INTERNATIONAL INC. | FY2027 | $400,000 | FY2027 |
| 172-2026-2027-Q1-1043376 | Pegasus Biotech Incorporated | FY2027 | $600,000 | FY2027 |
| 172-2026-2027-Q1-1042777 | E Sonar Inc. | FY2027 | $387,498 | FY2027 |
Cite as: Glassbox record view · Federal grants & contributions · 172-2018-2019-Q3-911219 · retrieved 2026-11-14.